NCT03270839View on ClinicalTrials.gov

Motion Sickness Medications and Vestibular Time Constant

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

January 1, 2020

Conditions
Drug Reaction
Interventions
DRUG

Bonine 25Mg Chewable Tablet

Motion sickness drug

DRUG

Kwells

Motion sickness drug

DRUG

Placebo Oral Tablet

No active substance in the tablet

Trial Locations (1)

Unknown

Israeli Navy Medical Institute, Haifa

All Listed Sponsors
lead

Medical Corps, Israel Defense Force

OTHER

NCT03270839 - Motion Sickness Medications and Vestibular Time Constant | Biotech Hunter | Biotech Hunter